Position in ADPT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$0
New position
Shares Held
6,898
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Gibbs Wealth Management holds $3,954,246 across 6 Diagnostics & Research names. ADPT ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,074 | $1,510,963 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,500 | $842,835 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
1,221 | $586,311 | |
| 4 | GH |
Guardant Health, Inc.
|
5,935 | $548,215 | |
| 5 | ILMN |
Illumina, Inc.
|
3,780 | $465,922 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
This page
|
6,898 | $0 |
All Filings in ADPT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 27,592 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||